Scott Scheffler v. HHS - Twinrix, Henoch Schoenlein purpura (2023)

Filed 2019-02-15Decided 2023-12-01Vaccine Twinrix
compensated$77,500

Case summary [AI summaries can sometimes make mistakes]

Scott Scheffler filed a petition on February 15, 2019, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered from Henoch Schoenlein purpura and its sequelae as a result of the Twinrix hepatitis A and B vaccine he received on or about May 2, 2018.

The respondent denied that Mr. Scheffler suffered from Henoch Schoenlein purpura or any other vascular or cardiac injury as a result of the vaccine, and denied that the vaccine caused his condition.

Despite these denials, both parties agreed to settle the case. They entered into a joint stipulation, which Special Master Katherine E.

Oler adopted as her decision. The stipulation awarded Mr.

Scheffler a lump sum of $77,500.00 as compensation for all damages available under the program. The decision was issued on December 1, 2023.

The public decision does not describe the onset, symptoms, medical tests, treatments, or expert witnesses. Petitioner counsel was Anne Carrion Toale, and respondent counsel was Austin Joel Egan.

Theory of causation

Petitioner Scott Scheffler alleged that the Twinrix hepatitis A and B vaccine administered on or about May 2, 2018, caused Henoch Schoenlein purpura and its sequelae. Respondent denied that the vaccine caused this condition or any other vascular or cardiac injury. The parties entered into a joint stipulation to settle the case, agreeing that the issues could be resolved with an award of compensation. Special Master Katherine E. Oler adopted the stipulation as her decision. The stipulation awarded Petitioner a lump sum of $77,500.00 for all damages. The public decision does not detail the specific theory of causation, medical experts, or the mechanism by which the vaccine allegedly caused the injury.

Source PDFs 3 total · 1 downloaded